A5029153309- Liver Diseases and Immunity
- Liver Disease Diagnosis and Treatment
- Pediatric Hepatobiliary Diseases and Treatments
- Neuroscience and Neuropharmacology Research
- Hepatitis Viruses Studies and Epidemiology
- Tryptophan and brain disorders
- Systemic Lupus Erythematosus Research
- Pharmacological Effects of Natural Compounds
- Pain Mechanisms and Treatments
- Diet and metabolism studies
- SARS-CoV-2 and COVID-19 Research
- Biochemical effects in animals
- Biomarkers in Disease Mechanisms
- Neurogenesis and neuroplasticity mechanisms
- Nerve injury and regeneration
- Celiac Disease Research and Management
Azienda Ospedaliera San Gerardo
2024-2025
Istituti di Ricovero e Cura a Carattere Scientifico
2024-2025
ERN GUARD-Heart
2025
ERN RARE-LIVER
2025
University of Milano-Bicocca
2022-2024
Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda
2024
University of Milan
2011
It is known that long-term treatment with antipsychotic drugs (APDs) produces neuroadaptive changes through the modulation of different proteins that, by enhancing neuronal plasticity and cellular resiliency, may improve core disease symptoms. The aim this study was to investigate ability chronic novel lurasidone modulate BDNF expression in hippocampus prefrontal cortex, under basal conditions or response an acute stress, a major precipitating element psychiatric disorders. By means...
Background: Impaired health-related quality of life (HRQoL) contributes to the overall disease burden in autoimmune hepatitis (AIH). This study aimed evaluate HRQoL people with AIH and identify potentially modifiable factors associated impaired using validated patient-reported outcome measures. Methods: Adult patients diagnosed at 12 European centers were enrolled this prospective, cross-sectional from July 2020-June 2023. was assessed Physical Component Score (PCS) Mental (MCS) 12-item...